Tonix Pharmaceuticals Holding Revenue, Growth & Competitor Profile

DBA TONIX PHARMACEUTICAL HOLDING COR
DBA TONIX PHARMACEUTICALS HOLDING CORP

Company Profile & Annual Report for Tonix Pharmaceuticals Holding

Access the complete profile.

Tonix Pharmaceuticals Holding Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	551112 Offices of Other Holding Companies
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services 541711 Research & Development in Biotechnology
Address	26 Main St Ste 101 Chatham, NJ 07928

Tonix Pharmaceuticals Holding's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Tonix Pharmaceuticals Holding's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Tonix Pharmaceuticals Holding is classified as operating in the Offices of Other Holding Companies industry, NAICS Code 551112.

Tonix Pharmaceuticals Holding is a publicly traded company on NGM using the ticker symbol TNXP. Detailed information on company financials and operating reports can be found here: NGM: TNXP

Tonix Pharmaceuticals Holding Annual Revenue and Growth Rate

Tonix Pharmaceuticals Holding	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Tonix Pharmaceuticals Holding's revenues are gauged from an analysis of company filings.

Investor Activity

Tonix Pharmaceuticals Holding has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 10, 2017	1	2%	$15 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Tonix Pharmaceuticals Holding is developing and marketing. Tonix Pharmaceuticals Holding doesn't have any recent trademark applications, indicating Tonix Pharmaceuticals Holding is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ANGSTRO-TECHNOLOGY Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders	08/03/2015
PROTECTIC Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders	05/20/2015
MODALTIN Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders	05/15/2015

See all trademarks and details in the Full Report.

Market Share of Tonix Pharmaceuticals Holding's Largest Competitors

A competitive analysis shows these companies are in the same general field as Tonix Pharmaceuticals Holding, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
HCA	Nashville, TN	100
ALLSTATE	Northbrook, IL	33
CAPITAL ONE NATIONAL ASSOCIATION	Mclean, VA	25
WORLD FUEL SERVICES COMPANY LLC SUCURSAL COLOMBIA	Bogota, D.C.	24
AIMBRIDGE PARENT	Plano, TX	20
TIME WARNER	New York, NY	18
OVG SPECTRA HOLDCO	Philadelphia, PA	13
GEICO	Washington, DC	12
DOMINION ENERGY NUCLEAR CONNECTICUT	Waterford, CT	12

Nearby Competitors

These companies are similar in business line and location to Tonix Pharmaceuticals Holding. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
TONIX PHARMACEUTICALS HOLDING	Chatham, NJ	100
AHS INVESTMENT	Morris Plains, NJ	67
E3 HR MANAGEMENT	Summit, NJ	12
ADVANCED FUND ADMINISTRATION	Summit, NJ	6
LEGACY CARE WEALTH	Morristown, NJ	1

Other Companies at 26 Main St, Chatham NJ

Company	Headquarters	Revenue ($ MM)
EDISON INVESTMENT ADVISORS	Chatham, NJ	100
SHIFT EMPLOYMENT LAW TRAINING	Chatham, NJ	54
STEPPING FORWARD COUNSELING CE	Chatham, NJ	0

Future Competition: Tonix Pharmaceuticals Holding's Fastest Growing Competitors

These companies are in the same general field as Tonix Pharmaceuticals Holding and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)